Specifically, we evaluated the impact of two Food & Drug Administration- (FDA-) approved PDE i(PDE-Is, cilostazol (a type III PDE-I) and sildenafil (a type V PDE-I), on bacterial survival and disease pathology in murine TB models. Here, ALDH7A1 is linked to tuberculosis.